Aprea Therapeutics, Inc. (APRE)

CIK 1781983 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Aprea Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Aug 28, 20268-K0001104659-26-102795
Aug 13, 2026SCHEDULE 13G/A0000935836-26-000399
Aug 12, 202610-Q0001104659-26-094544
Aug 12, 20268-K0001104659-26-094542
Jul 23, 20268-K0001104659-26-086254
Jun 17, 202640001104659-26-075279
Jun 17, 202640001104659-26-075282
Jun 17, 202640001104659-26-075278
Jun 17, 20268-K0001104659-26-075151
Jun 17, 202640001104659-26-075283
Jun 17, 202640001104659-26-075280
Jun 17, 202640001104659-26-075286
Jun 17, 202640001104659-26-075284
Jun 17, 202640001104659-26-075281
May 15, 2026SCHEDULE 13G0000902664-26-002544
May 15, 2026424B70001104659-26-062631
May 13, 20268-K0001104659-26-059734
May 13, 202610-Q0001104659-26-059743
Apr 30, 2026ARS0001104659-26-052063
Apr 30, 2026DEF 14A0001104659-26-052044
Apr 30, 2026DEFA14A0001104659-26-052049
Apr 29, 2026424B30001104659-26-051739
Apr 29, 2026EFFECT9999999995-26-001389
Apr 27, 2026SCHEDULE 13G/A0001493152-26-019073
Apr 22, 2026S-30001104659-26-046900